1. Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn

   • Ioannis Koutsavlis

   Review Article 03 October 2020 Pages: 1 - 10

2. Is there a gender effect in polycythemia vera?

   • Francesca Palandri
   • Barbara Mora
   • Lucia Catani

   Review Article Open access 02 October 2020 Pages: 11 - 25

   

3. An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia

   • Sylvie Stacy
   • Sujit Sheth
   • Wendy Cerenzia

   Original Article Open access 01 September 2020 Pages: 27 - 35

   

4. Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection

   • Abdulrahman A. Algassim
   • Assem A. Elghazaly
   • Mahmoud D. Aljurf

   Original Article 12 September 2020 Pages: 37 - 43

   

5. Characteristics of coagulation alteration in patients with COVID-19

   • Hong-chun Luo
   • Cheng-yan You
   • Yue-qiang Fu

   Original Article 20 October 2020 Pages: 45 - 52

   

6. Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine

   • Yang Lan
   • Lixian Chang
   • Xiaofan Zhu

   Original Article 08 October 2020 Pages: 53 - 61

   

7. Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia

   • Filipe Martins
   • Michael Kruszewski
   • Sabine Blum

   Original Article 16 June 2020 Pages: 63 - 78

   

8. Antibiotic use during cytarabine consolidation in acute myeloid leukemia

   • Colin A. Vale
   • Pamela C. Egan
   • John L. Reagan

   Original Article 01 September 2020 Pages: 79 - 84

   

9. Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India

   • Abhijit Phukan
   • Prakas Kumar Mandal
   • Tuphan K. Dolai

   Original Article 06 October 2020 Pages: 85 - 96

   

10. Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm

    • David C. A. Molitor
    • Peter Boor
    • Ines Gütgemann

    Original Article Open access 26 October 2020 Pages: 97 - 104

    

11. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis

    • Benedetta Rambaldi
    • Elisa Diral
    • Marta Serafini

    Original Article 21 October 2020 Pages: 105 - 116

    

12. Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019

    • Konnie Hebeda
    • Ludmila Boudova
    • Alexandar Tzankov

    Original Article 31 October 2020 Pages: 117 - 133

    

13. Low-dose ruxolitinib shows effective in treating myelofibrosis

    • Yunfan Yang
    • Hongmei Luo
    • Ling Pan

    Original Article 20 October 2020 Pages: 135 - 141

    

14. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

    • William J. Archibald
    • Kari G. Rabe
    • Sameer A. Parikh

    Original Article 01 June 2020 Pages: 143 - 155

    

15. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry

    • Shigeo Fuji
    • Shuhei Kida
    • Jun Ishikawa

    Original Article 21 October 2020 Pages: 157 - 165

    

16. Correction to: Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry

    • Shigeo Fuji
    • Shuhei Kida
    • Jun Ishikawa

    Correction 28 November 2020 Pages: 167 - 167

    

17. Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide

    • Jiao-Yu Zhao
    • Si-Ning Liu
    • Xiao-Dong Mo

    Original Article 07 November 2020 Pages: 169 - 180

    

18. Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors

    • Catharina Van Elssen
    • Gwendolyn van Gorkom
    • Gerard Bos

    Original Article Open access 28 October 2020 Pages: 181 - 187

    

19. Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas

    • Jae-Cheol Jo
    • Jin-Seok Kim
    • Won-Sik Lee

    Original Article 17 November 2020 Pages: 189 - 196

    

20. Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study

    • Yasuo Mori
    • Kensuke Sasaki
    • Fukuoka Blood and Marrow Transplantation Group

    Original Article 05 November 2020 Pages: 197 - 208

    

21. Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

    • Claire Seydoux
    • Michael Medinger
    • Nathan Cantoni

    Original Article Open access 23 October 2020 Pages: 209 - 216

    

22. Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia

    • Yasushi Onishi
    • Takehiko Mori
    • on behalf of the Adult Aplastic Anemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

    Original Article 09 October 2020 Pages: 217 - 228

    

23. Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study

    • Andry Van de Louw
    • Kathleen Twomey
    • Kevin Rakszawski

    Original Article 12 September 2020 Pages: 229 - 237

    

24. Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    • Boris Böll
    • Enrico Schalk
    • Marcus Hentrich

    Original Article Open access 30 September 2020 Pages: 239 - 259

    

25. Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study

    • Loes L. Cornelissen
    • Aukje L. Kreuger
    • Johanna G. van der Bom

    Original Article Open access 17 October 2020 Pages: 261 - 271

    

26. An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium

    • Qiaoyan Han
    • Lan Tao
    • Miao Sun

    Letter to the Editor 13 February 2020 Pages: 273 - 275

    

27. Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation

    • Annalen Bleckmann
    • Sascha Dierks
    • Gerald Wulf

    Letter to the Editor Open access 20 March 2020 Pages: 277 - 279

    

28. Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant

    • Manu Jamwal
    • Anu Aggarwal
    • Reena Das

    Letter to the Editor 27 March 2020 Pages: 281 - 283

    

29. Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma

    • Camille Debord
    • Jessie Bourcier
    • Soraya Wuillème

    Letter to the Editor 19 March 2020 Pages: 285 - 287

    

30. Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment

    • Lu Zhang
    • Wei Zhang
    • Daobin Zhou

    Letter to the Editor 25 April 2020 Pages: 289 - 291

    

31. Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia

    • Ozlem Ozbagcivan
    • Sevgi Akarsu
    • Emel Fetil

    Letter to the Editor 27 March 2020 Pages: 293 - 294

    

32. A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient

    • Jiaying Liu
    • Lijing Shen
    • Tingyu Yin

    Letter to the Editor 08 April 2020 Pages: 295 - 296

    

33. Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

    • Martin Kaiser
    • Meral Beksaç
    • Meletios A. Dimopoulos

    Correction 27 October 2020 Pages: 297 - 302

    

34. Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments

    • Alessia Bari
    • Raffaella Marcheselli
    • Fondazione Italiana Linfomi (Onlus)

    Correction 21 November 2020 Pages: 303 - 304

35. Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia

    • Ke Wan
    • Yafei Yin
    • Jianzhao Cheng

    Correction 16 October 2020 Pages: 305 - 305

36. Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China

    • Jing Ruan
    • Wei Zuo
    • Bing Han

    Correction 02 November 2020 Pages: 307 - 307